Ultimovacs

A pharmaceutical company developing novel immunotherapies against cancer.

HQ location

Oslo, Norway

Website

Launch date

2011

Employees

Market cap

Enterprise value

$35m

Share price

NOK13.86 ULTI.OL

Company register number

996713008

Recent deals

Zelluna Immunotherapy

https://twitter.com/ultimovacs https://www.linkedin.com/company/ultimovacs-as/

Authorizing premium user...